B-cell lymphoma clinical trials now open on the TrialWire Platform
ADELAIDE, AUS, Jan 5, 2022 - (ACN Newswire) - TrialWire(TM) is pleased to announce new B-cell lymphoma clinical studies are now available on the TrialWire Platform. More than 6 million people have used TrialWire over the past few years to find clinical trials that are right for them at clinics and specialist centers near them. The studies on TrialWire are available in Australia, New Zealand, and the U.S. They include new therapies in research for relapsed B-cell lymphoma run by leading lymphoma specialists. You can search for a study near you and find your local specialist team here. https://w...